A comparison of human G-Csf and human Gm-Csf given concurrently with anti-cancer chemotherapy

  • Authors:
    • Arthur J. Weiss
    • Richard D. Lackman
  • View Affiliations

  • Published online on: September 1, 2002     https://doi.org/10.3892/or.9.5.945
  • Pages: 945-950
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Granulocyte-colony-stimulating factor (G-Csf) and granulocyte-macrophagecolony-stimulating factor (GM-Csf) were each given concurrently with continuous infusion of doxorubicin, ifosphamide, or vinorelbine. Both cytokines enabled the dose intensity of these three anti-tumor agents to be substantially increased without an increase in drug toxicity. The effect of Gm-Csf as a stimulant of dendritic cell production and function was noted.

Related Articles

Journal Cover

September-October 2002
Volume 9 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Weiss AJ and Lackman RD: A comparison of human G-Csf and human Gm-Csf given concurrently with anti-cancer chemotherapy. Oncol Rep 9: 945-950, 2002.
APA
Weiss, A.J., & Lackman, R.D. (2002). A comparison of human G-Csf and human Gm-Csf given concurrently with anti-cancer chemotherapy. Oncology Reports, 9, 945-950. https://doi.org/10.3892/or.9.5.945
MLA
Weiss, A. J., Lackman, R. D."A comparison of human G-Csf and human Gm-Csf given concurrently with anti-cancer chemotherapy". Oncology Reports 9.5 (2002): 945-950.
Chicago
Weiss, A. J., Lackman, R. D."A comparison of human G-Csf and human Gm-Csf given concurrently with anti-cancer chemotherapy". Oncology Reports 9, no. 5 (2002): 945-950. https://doi.org/10.3892/or.9.5.945